How can companies address the U.S. FDA’s tougher stance and product, process and QMS V&V? One major failing is the lack of sufficient or targeted risk-based V&V Master Planning. Why do companies need a Validation Master Plan? What is it? How is it structured? Supporting systems/documents? How should each individual V&V plan be structured? Clarification of validation terms. Device, product, process, equipment, QMS, software V&V. What are the key components in understandable language? How is it run? What are the "must have" elements from ISO 14971 and ICH Q9 for hazard analysis and product risk management? How can these be integrated into a company's QMS?
Why Should You Attend:
FDA Warning Letters and recent high-profile recalls indicate major cGMP deficiencies in big-name device and pharma companies. One major failing is lack of sufficient or targeted risk-based Verification and Validation planning and execution. Another is confusion over terminology. Why do companies need a Validation Master Plan? What is it? How is it structured? Supporting systems/documents? What are the "must have" elements from ISO 14971 and ICH Q9 for hazard analysis and product risk management? How can these be integrated into a company's QMS? How to meet the similar V&V requirements of ISO 13485. Eliminate the confusion over V&V terminology. Develop a repeatable and CGMP-compliant V&V system.
Course Outline:
• Regulatory “Hot Buttons”
• V&V Background and Terms Defined
• The MVP / VMP
• Device / Product V&V
• Drug / Process V&V
• Software/firmware V&V
• QMS V&V
• Applicable guidance documents
• Suggested “Models”
• Data Sources / Metrics
What You Get:
• Training Materials
• Live Q&A Session with our Expert
• Participation Certificate
• Access to Signup Community (Optional)
• Reward Points
Who Will Benefit:
• Senior management
• Middle management
• QA/RA
• Operations
• Production
• Engineering
• SW programming/engineering
• Marketing
• Consultants
Raw Materials Risk Management In GMP Facilities: Avoiding GMP Non-Compliance Due to Raw Material Issues
Get Instant Access 90 Minutes View Program |
ISO 13485: 2016 - Understanding and Implementing The International Medical Device Quality Standard
Get Instant Access 90 Minutes View Program |
Two New FDA Draft Guidance Documents: Medical Devices and 510k Submission
Get Instant Access 90 Minutes View Program |
6-hour Virtual Seminar - FDA’s New Stringent Import Requirements Concerning International Consequences by Ex-FDA Official
Get Instant Access 360 Minutes View Program |
How to Prepare for and Host a FDA Inspection and Avoid 483’s (based on practical experience)
Get Instant Access 60 Minutes View Program |
Get Instant Access On-Demand Access
Preparing for the ICE Storm: What to Do During I 9 Audits and ICE Raids
Janette S. Levey
Human Resources
Get Instant Access On-Demand Access
OSHA Inspections and Investigations-How to Manage Them
Irwin Dobrushin
Environment Health and Safety | OSHA
Get Instant Access On-Demand Access
29 CFR 1904: OSHA's New Injury Recordkeeping E-Submission Rule
Occupational Safety and Health Administration
Get Instant Access On-Demand Access
Working with Excel Databases: Sort, Filter, Subtotal and More
Cathy Horwitz
Cross Industry | Skill Enhancement
Get Instant Access On-Demand Access
Writing Audit Reports
Jonnie T. Keith CIA, CFE, CGAP, CICA
Governance, Risk and Compliance
Get Instant Access On-Demand Access
BSA Reporting Requirements
Banking and Financial Services Industry
Get Instant Access On-Demand Access
Human Factors-Usability Based on ISO 62366
Medical Device | Diagnostic | Pharmaceutical | Biologics fields
Get Instant Access On-Demand Access
Chat GPT for Project Managers
Charles H. Paul
All FDA Regulated Industry